ClinicalTrials.gg
RecruitingNCT06241300EPICUpdated Jul 9, 2026

Executive Function and Parenting in Childhood

An interventional study of Chicago Parent Program in Disruptive Behavior Disorder, Childhood Onset, Disruptive Behavior and Executive Function, sponsored by University of Illinois at Chicago. Recruiting at 1 site in United States. Open to participants aged 4 Years and older. Per ClinicalTrials.gov, last updated 2026-07-09.

Sponsored by University of Illinois at Chicago · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Nov 2023; still recruiting 2 years 11 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
180
Allocation
Randomized
Ages
4 Years and older
Sex
All
01

Study summary

Deficits in executive functioning (EF) disproportionately impact children living in poverty and increase risk for psychopathology, particularly disruptive behavior disorders. This randomized clinical trial seeks to determine whether childhood EF, assessed across neural and behavioral units of analysis, is an experimental therapeutic target that can be directly modified through caregiver participation in the Chicago Parent Program (CPP), if increases in EF predict reduced disruptive behavior trajectories in low-income children over a short-term follow-up period, and identify which CPP-driven parenting skill improvements are the most influential in modifying EF. This work will contribute new knowledge as to whether a cost-efficient parenting intervention, developed for and with low-income families raising young children in poverty, can modify EF, a neural behavioral mechanism implicated in risk for childhood disruptive behavior problems.

Read the detailed description

Impairments in executive functioning (EF), cognitive processes that support self-regulation, disproportionately impact children living in poverty and increase vulnerability for childhood disruptive behavior, which trigger a cascade of mental health problems and psychosocial difficulties across the lifespan. Poverty-related stress and maladaptive parenting styles have been linked to alterations of neural and behavioral EF markers in children; despite this, no studies have studied if parenting prevention programs can directly target childhood EF, and through improving EF, reduce disruptive behaviors in at-risk children. The National Institute of Mental Health (NIMH) funded K23 Mentored Patient-Oriented Research Career Development Award project seeks to conduct a mechanistic randomized clinical trial to determine whether neural-behavioral indices of childhood EF is an experimental therapeutic target that can be modified via caregiver participation in the Chicago Parent Program. Consistent with the NIMH Research Domain Criteria framework, childhood EF will be assessed across brain and behavior measurement units. The second aim of the clinical trial seeks to evaluate whether increases in childhood neural-behavioral EF mediate the effects of CPP in reducing disruptive behavior problems over a short-term follow-up. A third exploratory aim of the project is to preliminarily test whether increases in specific parenting practices (discipline, scaffolding), previously linked to individual differences in EF, mediate the effects of CPP in predicting change in childhood neural-behavioral EF. The sample will include 90 Medicaid eligible parent-child (ages 4-5 years old) dyads and will employ a novel recruitment approach where the target child will have moderate-to-severe EF delays at baseline but does not meet diagnostic criteria for a disruptive behavior disorder.

02

Conditions studied

  • Disruptive Behavior Disorder, Childhood Onset
  • Disruptive Behavior
  • Executive Function
03

In context

Attention Deficit and Disruptive Behavior Disorders

60 studies on the registry are indexed under Attention Deficit and Disruptive Behavior Disorders; 7 are open to participants now.

This study's planned enrollment of 180 is above the median of 100 across 51 interventional studies indexed under Attention Deficit and Disruptive Behavior Disorders.

Browse Attention Deficit and Disruptive Behavior Disorders studies →

Lead sponsor

University of Illinois at Chicago is the lead sponsor of 506 studies on the registry; 120 are open to participants now.

Of its 32 completed or terminated interventional studies of FDA-regulated products, 19 (59%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children must be between the ages of 4 years old and 5 years, 11 months old
  • Parent must be the legal guardian of the target child and must live with the child full-time
  • Parents will be 18 years and older (no maximum age limit)
  • Only one child and one parent per family can participate in the study
  • Child is Medicaid eligible, defined as receiving Medicaid or eligible based on family income (up to 142 percent of the federal poverty level)
  • At enrollment the child will have moderate-to-severe (i.e., (sub)clinical) impairments in executive functioning as indicated by having a global executive composite standardized score greater than or equal to 60 on the Behavior Rating Inventory of Executive Function-Preschool Version (BRIEF-P), which will be completed by parents at the initial screen
  • Given that some assessment materials are only validated in English, parents and children for this study will need to be English-speaking
  • Child does not have a prior or current diagnosis of a disruptive behavior disorder based on Diagnostic Statistical Manual, Fifth Edition () criteria
  • Child is not currently receiving mental health services
  • Child does not take medications to treat emotional or behavioral problems
  • Child does not have a medical condition, such as epilepsy, that would interfere with the completion of study tasks
  • Child is not actively suicidal
  • Child does not have a history of psychosis or currently psychotic
  • Parent does not have a medical condition that would interfere with the completion of the study
  • Parent does not have an intellectual disability that would interfere with their ability to complete the study
  • Parent does not have a severe mental illness, active suicidal ideation, or current alcohol/substance abuse/dependence that would interfere with their ability to participate in the study
  • Child can have a current or past histories of psychiatric disorders (anxiety, mood, attention deficit hyperactivity disorder)
  • Parent can have current or past history of psychiatric disorders
  • Parent can be taking medications to treat mental health problems

Exclusion criteria

Exclusion Criteria:

  • Child is not between the ages of 4-5 years old
  • The parent is not the legal guardian of the target child
  • The parent does not live with the child full-time
  • The parent is younger than 18 years old
  • Child is not receiving Medicaid or Medicaid eligible
  • Child does not have (sub)clinical impairments in executive functioning as indicated by having a global executive composite standardized score greater than or equal to 60 on the BRIEF
  • Child and parent are not English-Speaking
  • Child has a prior or current diagnosis of a disruptive behavior disorder based on criteria
  • Child is currently receiving mental health services
  • Child currently takes medications to treat emotional or behavioral problems
  • Child has a medical condition, such as epilepsy, that would interfere with the completion of study tasks
  • Child is actively suicidal
  • Child has a history of psychosis or is currently psychotic
  • Parent is not willing to be randomly assigned to receive the Chicago Parent Program intervention or to the control condition where they will not receive an intervention
  • Parent has a medical condition that would interfere with the completion of the study
  • Parent has an intellectual disability that would interfere with their ability to complete the study
  • Parent has a severe mental illness and/or active suicidal ideation
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
180 participants (estimated)

Study arms

  • Experimental
    Chicago Parent Program

    Half of the dyads will be randomized to participant in the Chicago Parent Program (CPP), an evidence-based parenting preventive intervention for urban poor parents with children between the ages of 2-8 with behavior problems. The Chicago Parent Program consists of 12 groups sessions (11 weekly, 1 booster session). The groups are co-facilitated by two certified group leaders. Parents learn positive parenting and effective child behavior management skills, strategies to support the child's attention, literacy, and social skills, and stress management and problem solving techniques. Skill building is accomplished through watching videos of real-life parents and children during parent-child interactions, group discussion, role-playing, and weekly homework assignments.

    Behavioral: Chicago Parent Program

  • No intervention
    Control Condition

    Half of the dyads will be randomized to the no intervention arm.

Interventions

  • BehavioralChicago Parent Program

    Chicago Parent Program is an evidence-based group parenting intervention designed to reduce disruptive behavior in young children (2-8 years old).

06

What researchers measure

Primary outcomes

  1. Behavior Rating Inventory of Executive Function-Preschool Version (BRIEF-P)

    Parents will complete the BRIEF-P to assess their child's executive functioning, and the Global Executive Composite score will be used in the analysis.

    Time frame: an average of 4 months

  2. NIH Toolbox Early Childhood Cognitive Battery

    Children will be administered the NIH Toolbox Early Childhood Cognitive Battery to assess their executive functioning.

    Time frame: an average of 4 months

  3. EEG-Based indices of EF

    Children will complete the Zoo Go/No-Go computerized task while EEG is simultaneously recorded. Event-related potential components that index EF and theta spectral power and error-related interchannel phase frequency between frontocentral and frontolateral regions, will be used in the analyses.

    Time frame: an average of 4 months

Secondary outcomes

  1. Child Behavior Checklist (CBCL, 1.5-5)

    Parents will complete the Child Behavior Checklist in order to assess children's disruptive behavior symptoms.

    Time frame: through study completion, an average of 16 months

  2. Eyberg Child Behavior Inventory (ECBI)

    Parents will complete the Eyberg Child Behavior Inventory in order to assess children's disruptive behavior problems.

    Time frame: through study completion, an average of 16 months

  3. Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS)-COMPUTER (COMP)

    Parents will be administered the clinician administered the K-SADS-COMP, which is a web-based semi-structured interview to assess children's disruptive behavior symptoms and to determine if children meet criteria for a disruptive behavior disorder.

    Time frame: through study completion, an average of 16 months

Other outcomes

  1. Home EF Environment (HEFE)

    Parents will complete the Home EF Environment questionnaire to assess parental use of scaffolding practices with their child at home.

    Time frame: an average of 4 months

  2. Parenting Dimensions Inventory (PDI)

    Parents will complete the Parenting Dimensions Inventory to assess parental use of different disciplinary practices across various child-rearing situations and parental nurturance.

    Time frame: an average of 4 months

  3. Parenting Questionnaire (PQ)

    Parents will complete the Parenting Questionnaire to assess parental warmth, follow-through on discipline, and use of corporal punishment.

    Time frame: an average of 4 months

  4. Iowa Family Interaction Rating Scales (IFIRS)

    Parents will engage in three interaction tasks (Grocery Store Task, Free-Play, Clean-up) with their child during the laboratory visits, which will be video recorded for later coding of parenting behaviors (warmth, sensitivity, harsh discipline, scaffolding) using subscales adapted from the Iowa Family Interaction Rating Scales (IFIRS).

    Time frame: an average of 4 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2023 (actual). Primary completion is estimated for Feb 2028, 51 months after the start.

Of 22 interventional studies with no phase under Attention Deficit and Disruptive Behavior Disorders, half reached primary completion within 39 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 68. This study's planned 51 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 17, 2024
First posted
Feb 5, 2024
StartActual
Nov 20, 2023
Primary completionEst.
Feb 28, 2028
CompletionEst.
Mar 31, 2028
Last update
Jul 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06241300
Responsible party
Sponsor
First posted
Feb 5, 2024
Start date
Nov 20, 2023
Primary completion
Feb 28, 2028 (estimated)
Completion
Mar 31, 2028 (estimated)
Last update
Jul 9, 2026

Study contacts

Jennifer Suor, PhD
Contact
jesuor@uic.edu
7733208989

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion